CONGRESS ASSET MANAGEMENT CO has opened a new $90.0M position in $VCYT, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 09-30-2026 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $VCYT.
$VCYT Hedge Fund Activity
We have seen 200 institutional investors add shares of $VCYT stock to their portfolio, and 143 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CONGRESS ASSET MANAGEMENT CO added 1,954,198 shares (+inf%) to their portfolio in Q3 2026, for an estimated $89,971,275
- DRIEHAUS CAPITAL MANAGEMENT LLC added 1,045,826 shares (+inf%) to their portfolio in Q2 2026, for an estimated $61,421,360
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 939,983 shares (+inf%) to their portfolio in Q2 2026, for an estimated $55,205,201
- ARROWMARK COLORADO HOLDINGS LLC removed 932,117 shares (-67.8%) from their portfolio in Q2 2026, for an estimated $54,743,231
- ARK INVESTMENT MANAGEMENT LLC removed 757,867 shares (-24.8%) from their portfolio in Q2 2026, for an estimated $44,509,528
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 641,171 shares (+81.1%) to their portfolio in Q2 2026, for an estimated $37,655,972
- ARTEMIS INVESTMENT MANAGEMENT LLP added 638,933 shares (+inf%) to their portfolio in Q2 2026, for an estimated $37,524,535
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$VCYT Insider Trading Activity
$VCYT insiders have traded $VCYT stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $VCYT stock by insiders over the last 6 months:
- MARC STAPLEY (Chief Executive Officer) sold 138,051 shares for an estimated $6,919,585
- JONATHAN WYGANT (VP, Chief Accounting Officer) sold 24,000 shares for an estimated $1,089,624
- JOHN LEITE (Global Chief Commercial Off) has made 0 purchases and 2 sales selling 17,990 shares for an estimated $860,332.
- PHILLIP G. FEBBO (Chief Scientific & Med Officer) has made 0 purchases and 2 sales selling 13,110 shares for an estimated $564,409.
- ROBERT S EPSTEIN sold 10,000 shares for an estimated $440,129
- REBECCA CHAMBERS (Chief Financial Officer) has made 0 purchases and 4 sales selling 7,213 shares for an estimated $334,476.
- ANNIE MCGUIRE (EVP, General Counsel) has made 0 purchases and 4 sales selling 6,430 shares for an estimated $298,248.
- JENS HOLSTEIN sold 5,000 shares for an estimated $204,747
- KARIN EASTHAM has made 0 purchases and 2 sales selling 3,729 shares for an estimated $197,234.
- MUNA BHANJI sold 1,864 shares for an estimated $80,096
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$VCYT Government Contracts
We have seen $1,721,949 of award payments to $VCYT over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- TO - PROSTATE TESTING: $345,180
- DECIPHER: GENOMIC SEQUENCING CLASSIFIER: $324,059
- VERACYTE PROSTATE CANCER TESTING PACKAGING AND TRANSPORT VA SAN FRANCISCO: $259,247
- VERACYTE DECIOPHER PROSTATE TESTING NORTHPORT VAMC FSS: $129,623
- DECIPHER PROSTATE TESTING ANN ARBOR, SAGINAW, BATTLE CREEK - BASE: $129,623
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$VCYT Price Targets
Multiple analysts have issued price targets for $VCYT recently. We have seen 6 analysts offer price targets for $VCYT in the last 6 months, with a median target of $49.5.
Here are some recent targets:
- Tejas Savant from Morgan Stanley set a target price of $47.0 on 07/09/2026
- Subbu Nambi from Guggenheim set a target price of $65.0 on 06/29/2026
- Mike Matson from Needham set a target price of $57.0 on 06/01/2026
- Kyle Mikson from Canaccord Genuity set a target price of $42.0 on 05/06/2026
- Lu Li from UBS set a target price of $52.0 on 05/06/2026
- Tycho Peterson from Jefferies set a target price of $45.0 on 04/13/2026
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $VCYT ticker page for more data.
